Pfizer Just Locked Next Growth Path: What Investors Should Know
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Which Investors Should Avoid Robo Advisors outlines situations where automated options may underperform. This intro highlights alternatives to consider.
28,175 articlesPfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Craving a position in SpaceX before it goes public? An ETF that blends public and late-stage private exposure, like X...
On a June trading day, Payoneer Global surged on takeover chatter, highlighting how M&A rumors can move fintech names...
As AMD gears up for its Aug. 4 earnings release, the stock’s unstoppable momentum raises questions: what would truly ...
In a world of hot bets and fast trades, one blue-chip name stands out as a potential core holding. Learn why Johnson ...
Through the first three months of 2026, the stock market diverged: the S&P 500 fell, while smaller firms outperformed...
If you own rental real estate, you’ve probably wondered how to boost cash flow without waiting years for upside. A co...
When a payments giant tops the headline numbers, savvy investors look beyond the beat. This article breaks down why v...
A major federal loan initiative aims to revitalize nuclear power by backing five new projects with $17.5 billion. Thi...
Meta Platforms stock surged this week as investors cheered hints of in-house AI chips and bigger cloud capacity. We b...
Oracle posted a strong top line for fiscal Q3 2026, but a ballooning capex bill pushed free cash flow deep into negat...
As investors scan petco (woof) 2025 earnings, they will weigh store growth, online momentum, and margin discipline. T...